Examining risperidone use in those diagnosed with autism 1 year after FDA approval. | J Clin Psychiatry;71(5): 651-2, 2010 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Examining risperidone use in those diagnosed with autism 1 year after FDA approval.

Valdovinos, Maria G; Bailey, Linda; Taylor, Steve L.

J Clin Psychiatry ; 71(5): 651-2, 2010 May.

Article in En | MEDLINE | ID: mdl-20492856

Subject(s)

Antipsychotic Agents/therapeutic use; Autistic Disorder/drug therapy; Risperidone/therapeutic use; Adolescent; Adult; Age of Onset; Autistic Disorder/complications; Child; Humans; Intellectual Disability/complications; Middle Aged; Young Adult

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autistic Disorder / Antipsychotic Agents / Risperidone Type of study: Diagnostic_studies Limits: Adolescent / Adult / Child / Humans / Middle aged Language: En Journal: J Clin Psychiatry Year: 2010 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autistic Disorder / Antipsychotic Agents / Risperidone Type of study: Diagnostic_studies Limits: Adolescent / Adult / Child / Humans / Middle aged Language: En Journal: J Clin Psychiatry Year: 2010 Document type: Article